The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
The p38 Pathway: From Biology to Cancer Therapy
Open accessAbstract
The p38 MAPK pathway is well known for its role in transducing stress signals from the environment. Many key players and regulatory mechanisms of this signaling cascade have been described to some extent. Nevertheless, p38 participates in a broad range of cellular activities, for many of which detailed molecular pictures are still lacking. Originally described as a tumor-suppressor kinase for its inhibitory role in RAS-dependent transformation, p38 can also function as a tumor promoter, as demonstrated by extensive experimental data. This finding has prompted the development of specific inhibitors that have been used in clinical trials to treat several human malignancies, although without much success to date. However, elucidating critical aspects of p38 biology, such as isoform-specific functions or its apparent dual nature during tumorigenesis, might open up new possibilities for therapy with unexpected potential. In this review, we provide an extensive description of the main biological functions of p38 and focus on recent studies that have addressed its role in cancer. Furthermore, we provide an updated overview of therapeutic strategies targeting p38 in cancer and promising alternatives currently being explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Matsuyama, W., Faure, M., & Yoshimura, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3520 · Cited by 51
RetractedActivation and function of the MAPKs and their substrates, the MAPK-activated protein kinases
Cargnello, M., & Roux, P. P. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-10 · Cited by 3,274
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
Signal integration by JNK and p38 MAPK pathways in cancer development
Wagner, E. F., & Nebreda, Á. R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2694 · Cited by 2,586
Matrix metalloproteinases and tumor metastasis
Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Mechanisms and functions of p38 MAPK signalling
Cuadrado, A., & Nebreda, A. R. (2010) · Biochemical Journal · doi:10.1042/bj20100323 · Cited by 1,676
Independent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms
Dérijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Science · doi:10.1126/science.7839144 · Cited by 1,555
Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
Kyriakis, J. M., & Avruch, J. (2012) · Physiological Reviews · doi:10.1152/physrev.00028.2011 · Cited by 1,466
p38 MAP-Kinases pathway regulation, function and role in human diseases
Cuenda, A., & Rousseau, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.010 · Cited by 1,400
On the Origin of Cancer Metastasis
Seyfried, T. N., & Huysentruyt, L. C. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.40 · Cited by 1,196
Mechanisms of disseminated cancer cell dormancy: an awakening field
Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3793 · Cited by 1,126
A conserved docking motif in MAP kinases common to substrates, activators and regulators
Tanoue, T., Adachi, M., Moriguchi, T., & Nishida, E. (2000) · Nature Cell Biology · doi:10.1038/35000065 · Cited by 816
Encoding and Decoding Cellular Information through Signaling Dynamics
Purvis, J. E., & Lahav, G. (2013) · Cell · doi:10.1016/j.cell.2013.02.005 · Cited by 798
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
Owens, D. M., & Keyse, S. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210412 · Cited by 777
p38MAPK: stress responses from molecular mechanisms to therapeutics
Coulthard, L. R., White, D. E., Jones, D. L., McDermott, M. F., & Burchill, S. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.06.005 · Cited by 691
Cell Cycle Regulation by Checkpoints
Barnum, K. J., & O’Connell, M. J. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-4939-0888-2_2 · Cited by 601
Reinhardt, H. C., Aslanian, A. S., Lees, J. A., & Yaffe, M. B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.024 · Cited by 596
p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes
Engel, F. B., Schebesta, M., Duong, M. T., Lu, G., Ren, S., Madwed, J. B., Jiang, H., Wang, Y., & Keating, M. T. (2005) · Genes & Development · doi:10.1101/gad.1306705 · Cited by 595
Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
Grivennikov, S. I., & Karin, M. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140145 · Cited by 560
High-Sensitivity Measurements of Multiple Kinase Activities in Live Single Cells
Regot, S., Hughey, J. J., Bajar, B. T., Carrasco, S., & Covert, M. W. (2014) · Cell · doi:10.1016/j.cell.2014.04.039 · Cited by 551
Enslen, H., Raingeaud, J., & Davis, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1741 · Cited by 539
MAPKK-Independent Activation of p38α Mediated by TAB1-Dependent Autophosphorylation of p38α
Ge, B., Gram, H., Di Padova, F., Huang, B., New, L., Ulevitch, R. J., Luo, Y., & Han, J. (2002) · Science · doi:10.1126/science.1067289 · Cited by 534
Essential Role of p38α MAP Kinase in Placental but Not Embryonic Cardiovascular Development
Adams, R. H., Porras, A., Alonso, G., Jones, M., Vintersten, K., Panelli, S., Valladares, A., Perez, L., Klein, R., & Nebreda, A. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00014-6 · Cited by 516
Mechanism of p38 MAP kinase activation in vivo
Brancho, D., Tanaka, N., Jaeschke, A., Ventura, J.-J., Kelkar, N., Tanaka, Y., Kyuuma, M., Takeshita, T., Flavell, R. A., & Davis, R. J. (2003) · Genes & Development · doi:10.1101/gad.1107303 · Cited by 490
Sakurai, T., He, G., Matsuzawa, A., Yu, G.-Y., Maeda, S., Hardiman, G., & Karin, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.016 · Cited by 487
p38 and Extracellular Signal-Regulated Kinases Regulate the Myogenic Program at Multiple Steps
Wu, Z., Woodring, P. J., Bhakta, K. S., Tamura, K., Wen, F., Feramisco, J. R., Karin, M., Wang, J. Y. J., & Puri, P. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.3951-3964.2000 · Cited by 474
Regulating mammalian checkpoints through Cdc25 inactivation
Donzelli, M., & Draetta, G. F. (2003) · EMBO reports · doi:10.1038/sj.embor.embor887 · Cited by 438
Takekawa, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6517 · Cited by 419
Regulated nucleo/cytoplasmic exchange of HOG1 MAPK requires the importin beta homologs NMD5 and XPO1
Ferrigno, P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5606 · Cited by 418
Manke, I. A., Nguyen, A., Lim, D., Stewart, M. Q., Elia, A. E. H., & Yaffe, M. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.021 · Cited by 416
Bulavin, D. V., Phillips, C., Nannenga, B., Timofeev, O., Donehower, L. A., Anderson, C. W., Appella, E., & Fornace, A. J. (2004) · Nature Genetics · doi:10.1038/ng1317 · Cited by 409
p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis
Dolado, I., Swat, A., Ajenjo, N., De Vita, G., Cuadrado, A., & Nebreda, A. R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.013 · Cited by 404
p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci
Simone, C., Forcales, S. V., Hill, D. A., Imbalzano, A. N., Latella, L., & Puri, P. L. (2004) · Nature Genetics · doi:10.1038/ng1378 · Cited by 398
Essential role for p38α mitogen-activated protein kinase in placental angiogenesis
Mudgett, J. S., Ding, J., Guh-Siesel, L., Chartrain, N. A., Yang, L., Gopal, S., & Shen, M. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316397 · Cited by 372
p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway
Hui, L., Bakiri, L., Mairhorfer, A., Schweifer, N., Haslinger, C., Kenner, L., Komnenovic, V., Scheuch, H., Beug, H., & Wagner, E. F. (2007) · Nature Genetics · doi:10.1038/ng2033 · Cited by 352
Requirement for p38α in Erythropoietin Expression
Tamura, K., Sudo, T., Senftleben, U., Dadak, A. M., Johnson, R., & Karin, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00027-1 · Cited by 340
Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2
Ben-Levy, R., Hooper, S., Wilson, R., Paterson, H. F., & Marshall, C. J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70442-7 · Cited by 338
Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions
BIONDI, R. M., & NEBREDA, A. R. (2003) · Biochemical Journal · doi:10.1042/bj20021641 · Cited by 334
Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases
Salvador, J. M., Mittelstadt, P. R., Guszczynski, T., Copeland, T. D., Yamaguchi, H., Appella, E., Fornace, A. J., & Ashwell, J. D. (2005) · Nature Immunology · doi:10.1038/ni1177 · Cited by 306
p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation
Ventura, J. J., Tenbaum, S., Perdiguero, E., Huth, M., Guerra, C., Barbacid, M., Pasparakis, M., & Nebreda, A. R. (2007) · Nature Genetics · doi:10.1038/ng2037 · Cited by 304
Role of mitogen-activated protein kinase kinase kinases in signal integration
Cuevas, B. D., Abell, A. N., & Johnson, G. L. (2007) · Oncogene · doi:10.1038/sj.onc.1210409 · Cited by 294
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis
Curtis, M., Kenny, H. A., Ashcroft, B., Mukherjee, A., Johnson, A., Zhang, Y., Helou, Y., Batlle, R., Liu, X., Gutierrez, N., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.007 · Cited by 290
Tanoue, T., Maeda, R., Adachi, M., & Nishida, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.466 · Cited by 285
Regulation of skeletal muscle gene expression by p38 MAP kinases
Lluís, F., Perdiguero, E., Nebreda, A. R., & Muñoz-Cánoves, P. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.11.002 · Cited by 279
Feedback control of the protein kinase TAK1 by SAPK2a/p38
Cheung, P. C. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg552 · Cited by 278
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression
Jin, X., Ding, D., Yan, Y., Li, H., Wang, B., Ma, L., Ye, Z., Ma, T., Wu, Q., Rodrigues, D. N., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.10.034 · Cited by 257
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23
Li, J., Yang, Y., Peng, Y., Austin, R. J., van Eyndhoven, W. G., Nguyen, K. C. Q., Gabriele, T., McCurrach, M. E., Marks, J. R., Hoey, T., et al. (2002) · Nature Genetics · doi:10.1038/ng888 · Cited by 246
Puri, P. L., Wu, Z., Zhang, P., Wood, L. D., Bhakta, K. S., Han, J., Feramisco, J. R., Karin, M., & Wang, J. Y. J. (2000) · Genes & Development · doi:10.1101/gad.14.5.574 · Cited by 244
Regulation of PKD by the MAPK p38δ in Insulin Secretion and Glucose Homeostasis
Sumara, G., Formentini, I., Collins, S., Sumara, I., Windak, R., Bodenmiller, B., Ramracheya, R., Caille, D., Jiang, H., Platt, K. A., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.018 · Cited by 244
Lafarga, V., Cuadrado, A., Lopez de Silanes, I., Bengoechea, R., Fernandez-Capetillo, O., & Nebreda, A. R. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00210-09 · Cited by 242
Reinhardt, H. C., Hasskamp, P., Schmedding, I., Morandell, S., van Vugt, M. A. T. M., Wang, X., Linding, R., Ong, S.-E., Weaver, D., Carr, S. A., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.018 · Cited by 238
Li, J., Miller, E. J., Ninomiya-Tsuji, J., Russell, R. R., & Young, L. H. (2005) · Circulation Research · doi:10.1161/01.res.0000187458.77026.10 · Cited by 234
Kumar, B., Koul, S., Petersen, J., Khandrika, L., Hwa, J. S., Meacham, R. B., Wilson, S., & Koul, H. K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2918 · Cited by 217
Jin, S., Tong, T., Fan, W., Fan, F., Antinore, M. J., Zhu, X., Mazzacurati, L., Li, X., Petrik, K. L., Rajasekaran, B., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1206034 · Cited by 207
TAO kinases mediate activation of p38 in response to DNA damage
Raman, M., Earnest, S., Zhang, K., Zhao, Y., & Cobb, M. H. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601668 · Cited by 206
Chinnam, M., & Goodrich, D. W. (2011) · Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00005-x · Cited by 199
The p38 Pathway Provides Negative Feedback for Ras Proliferative Signaling
Chen, G., Hitomi, M., Han, J., & Stacey, D. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002856200 · Cited by 193
The Stress Kinase p38α as a Target for Cancer Therapy
Igea, A., & Nebreda, A. R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0173 · Cited by 189
Selective p38 Activation in Human Non–Small Cell Lung Cancer
Greenberg, A. K., Basu, S., Hu, J., Yie, T.-A., Tchou-Wong, K. M., Rom, W. N., & Lee, T. C. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.5.4689 · Cited by 172
Yu-Lee, L.-Y., Yu, G., Lee, Y.-C., Lin, S.-C., Pan, J., Pan, T., Yu, K.-J., Liu, B., Creighton, C. J., Rodriguez-Canales, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1051 · Cited by 172
Self-citationGupta, J., del Barco Barrantes, I., Igea, A., Sakellariou, S., Pateras, I. S., Gorgoulis, V. G., & Nebreda, A. R. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.019 · Cited by 166
Transcriptional repression mediated by the p53 tumour suppressor
Ho, J., & Benchimol, S. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401191 · Cited by 166
Haq, R., Brenton, J. D., Takahashi, M. T., Finan, D., Finkielsztein, A., Damaraju, S., Rottapel, R. K., & Zanke, B. W. (2002) · PubMed · Cited by 165
Urosevic, J., García‐Albéniz, X., Planet, E., Real, S., Céspedes, M. V., Guiu, M., Fernández, E., Bellmunt, A., Gawrzak, S., Pavlović, M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2977 · Cited by 163
Differential activation of p38MAPK isoforms by MKK6 and MKK3
Rémy, G., Risco, A. M., Iñesta-Vaquera, F., González‐Terán, B., Sabio, G., Davis, R. J., & Cuenda, A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.020 · Cited by 155
Macůrek, L., Lindqvist, A., Voets, O., Kool, J., Vos, H. R., & Medema, R. H. (2010) · Oncogene · doi:10.1038/onc.2009.501 · Cited by 153
p38 Isoforms Have Opposite Effects on AP-1-dependent Transcription through Regulation of c-Jun
Pramanik, R., Qi, X.-M., Borowicz, S., Choubey, D., Schultz, R. M., Han, J., & Chen, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207732200 · Cited by 152
Roles of p38α mitogen‐activated protein kinase in mouse models of inflammatory diseases and cancer
Gupta, J. R. P., & Nebreda, Á. R. (2015) · FEBS Journal · doi:10.1111/febs.13250 · Cited by 152
Kishi, H., Nakagawa, K., Matsumoto, M., Suga, M., Ando, M., Taya, Y., & Yamaizumi, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105134200 · Cited by 150
Leelahavanichkul, K., Amornphimoltham, P., Molinolo, A., Basile, J. R., Koontongkaew, S., & Gutkind, J. S. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.10.003 · Cited by 145
Pereira, L., Igea, A., Cánovas, B., Dolado, I., & Nebreda, Á. R. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302732 · Cited by 142
Wong, E. S. M., Guezennec, X. L., Demidov, O. N., Marshall, N. T., Wang, S. T., Krishnamurthy, J., Sharpless, N. E., Dunn, N. R., & Bulavin, D. V. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.05.009 · Cited by 141
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer
Gawrzak, S., Rinaldi, L., Gregorio, S., Arenas, E. J., Salvador, F., Urosevic, J., Figueras-Puig, C., Rojo, F., Barrantes, I. D. B., Cejalvo, J. M., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-017-0021-z · Cited by 140
Diverse Mechanisms of Myocardial p38 Mitogen-Activated Protein Kinase Activation
Tanno, M., Bassi, R., Gorog, D. A., Saurin, A. T., Jiang, J., Heads, R. J., Martin, J. W., Davis, R. J., Flavell, R. A., & Marber, M. S. (2003) · Circulation Research · doi:10.1161/01.res.0000083490.43943.85 · Cited by 139
Soni, S., Anand, P., & Padwad, Y. S. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1115-1 · Cited by 132
P38-γ–dependent gene silencing restricts entry into the myogenic differentiation program
Gillespie, M. A., Le Grand, F., Scimè, A., Kuang, S., von Maltzahn, J., Seale, V., Cuenda, A., Ranish, J. A., & Rudnicki, M. A. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200907037 · Cited by 131 · cited 1×
“The study of genetically modified mice shows that p38α ablation has an important role in myoblast differentiation and myotube formation [61], whereas other forms of the kinase such as p38γ may contribute to regulating the expansion of satellite cells [62].”
Backgroundp38 MAPK Autophosphorylation Drives Macrophage IL-12 Production during Intracellular Infection
Kim, L., Río, L. D., Butcher, B. A., Mogensen, T. H., Paludan, S. R., Flavell, R. A., & Denkers, E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4178 · Cited by 130
Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells
Guo, X., Ma, N., Wang, J., Song, J., Bu, X., Cheng, Y., Sun, K., Xiong, H., Jiang, G., Zhang, B., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-375 · Cited by 130
CXCL12 and C5a trigger cell migration via a PAK1/2-p38α MAPK-MAPKAP-K2-HSP27 pathway
Rousseau, S., Dolado, I., Beardmore, V. A., Shpiro, N., Márquez, R., Nebreda, Á. R., Arthur, J. S. C., Case, L. C., Tessier‐Lavigne, M., Gaestel, M., et al. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.02.006 · Cited by 124
Thoms, H. C., Dunlop, M. G., & Stark, L. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1038 · Cited by 116
Cánovas, B., Igea, A., Sartori, A. A., Gomis, R. R., Paull, T. T., Isoda, M., Perez‐Montoyo, H., Serra, V., González‐Suárez, E., Stracker, T. H., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.010 · Cited by 114
Molecular Pathways: Mitogen-Activated Protein Kinase Pathway Mutations and Drug Resistance
Pritchard, A. L., & Hayward, N. K. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0383 · Cited by 112
Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer
Stramucci, L., Pranteda, A., & Bossi, G. (2018) · Cancers · doi:10.3390/cancers10050131 · Cited by 109
p38γ is essential for cell cycle progression and liver tumorigenesis
Tomás‐Loba, A., Manieri, E., González‐Terán, B., Mora, A., Leiva‐Vega, L., Santamans, A. M., Romero-Becerra, R., Rodríguez, E., Chocano, A. P., Feixas, F., et al. (2019) · Nature · doi:10.1038/s41586-019-1112-8 · Cited by 109
Mechanisms regulating the nuclear translocation of p38 MAP kinase
Gong, X., Ming, X., Deng, P., & Jiang, Y. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22675 · Cited by 107
Nicola, G. F. D., Martin, E. D., Chaikuad, A., Bassi, R., Clark, J., Martino, L., Verma, S., Sicard, P., Tata, R., Atkinson, R. A., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2668 · Cited by 107
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics
Lalaoui, N., Hänggi, K., Brumatti, G., Chau, D., Nguyen, N.-Y. N., Vasilikos, L., Spilgies, L. M., Heckmann, D. A., Ma, C., Ghisi, M., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.01.006 · Cited by 106
Yu, W., Imoto, I., Inoue, J., Onda, M., Emi, M., & Inazawa, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209899 · Cited by 104
Alonso, G., Ambrosino, C., Jones, M., & Nebreda, Á. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007835200 · Cited by 104
p38γ and p38δ: From Spectators to Key Physiological Players
Cuenda, A., & Sanz‐Ezquerro, J. J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.02.008 · Cited by 103
del Reino, P., Alsina‐Beauchamp, D., Escós, A., Cerezo-Guisado, M. I., Risco, A., Aparicio, N., Zur, R., Fernandez-Estévez, M., Collantes, E., Montáns, J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0870 · Cited by 101
Gubern, A., Joaquin, M., Marqués, M., Maseres, P., Garcı́a-Garcı́a, J., Amat, R., González-Nuñez, D., Oliva, B., Real, F. X., de Nadal, E., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.015 · Cited by 96
Self-citationTrempolec, N., Dave-Coll, N., & Nebreda, Á. R. (2013) · Cell · doi:10.1016/j.cell.2013.01.047 · Cited by 91
Doza, Y. N., Cuenda, A., Thomas, G. M., Cohen, P., & Nebreda, Á. R. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00346-b · Cited by 90
Zhang, Y., Mei, Z., Wu, J., & Wang, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801703200 · Cited by 90
Perdiguero, E., Ruiz‐Bonilla, V., Serrano, A. L., & Muñoz‐Cánoves, P. (2007) · Cell Cycle · doi:10.4161/cc.6.11.4315 · Cited by 89
Wada, M., Canals, D., Adada, M. M., Coant, N., Salama, M., Helke, K. L., Arthur, J. S. C., Shroyer, K. R., Kitatani, K., Obeid, L. M., et al. (2017) · Oncogene · doi:10.1038/onc.2017.274 · Cited by 76
p38δ Mitogen-Activated Protein Kinase Is Essential for Skin Tumor Development in Mice
Schindler, E. M., Hindes, A. E., Gribben, E. L., Burns, C. J., Yin, Y., Lin, M., Owen, R. J., Longmore, G. D., Kissling, G. E., Arthur, J. S. C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4455 · Cited by 75
Bonney, E. A. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12652 · Cited by 73
Whole genome analysis of p38 SAPK-mediated gene expression upon stress
Ferreiro, I., Joaquin, M., Islam, A. B. M. M. K., Goméz-López, G., Barragán, M., Lombardía, L., Domínguez, O., Pisano, D. G., López-Bigas, N., Nebreda, Á. R., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-144 · Cited by 72
Self-citationVergote, I. B., Heitz, F., Buderath, P., Powell, M. A., Sehouli, J., Lee, C. M., Hamilton, A. L., Fiorica, J. V., Moore, K. N., Teneriello, M. G., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.11.006 · Cited by 71
Gil-Araujo, B., Toledo-Lobo, M. V., Gutiérrez‐Salmerón, M. T., Gutiérrez-Pitalúa, J., Ropero, S., Angulo, J. C., Chiloeches, A., & Lasa, M. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.08.012 · Cited by 69
Essential Role of p38γ in K-Ras Transformation Independent of Phosphorylation
Tang, J., Qi, X.-M., Mercola, D., Han, J., & Chen, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500699200 · Cited by 68
Efimova, T., Broome, A., & Eckert, R. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.8167-8183.2004 · Cited by 68
Suarez‐Cuervo, C., Merrell, M. A., Watson, L., Harris, K. W., Rosenthal, E. L., Väänänen, H. K., & Selander, K. S. (2004) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-3503-x · Cited by 68
Faust, D., Schmitt, C. R., Oesch, F., Oesch‐Bartlomowicz, B., Schreck, I., Weiß, C., & Dietrich, C. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-6 · Cited by 64
Genetic analysis of specific and redundant roles for p38α and p38β MAPKs during mouse development
Barrantes, I. D. B., Coya, J. M., Maina, F., Arthur, J. S. C., & Nebreda, Á. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015013108 · Cited by 62
Joaquin, M., Gubern, A., González-Nuñez, D., Ruiz, E. J., Ferreiro, I., de Nadal, E., Nebreda, Á. R., & Posas, F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.122 · Cited by 58
Self-citationSwat, A., Dolado, I., Rojas, J. M., & Nebreda, Á. R. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01955-08 · Cited by 54
Im, J., & Lee, J.-K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802851200 · Cited by 53
Bollaert, E., Serra, A. D. R., & Demoulin, J. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03012-9 · Cited by 52
p38γ MAPK is required for inflammation-associated colon tumorigenesis
Yin, N. B., Qi, X., Tsai, S., Lu, Y., Basir, Z., Oshima, K., Thomas, J. P., Myers, C. R., Stoner, G. D., & Chen, G. (2015) · Oncogene · doi:10.1038/onc.2015.158 · Cited by 47
Limoge, M., Safina, A. F., Truskinovsky, A. M., Aljahdali, I. A. M., Zonneville, J., Gruevski, A., Arteaga, C. L., & Bakin, A. V. (2017) · Oncotarget · doi:10.18632/oncotarget.18755 · Cited by 46
Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis
Henriques, A. R., Koliaraki, V., & Kollias, G. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805683115 · Cited by 46
MK2 regulates the early stages of skin tumor promotion
Johansen, C., Vestergaard, C., Kragballe, K., Kollias, G. A., Gaestel, M., & Iversen, L. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp238 · Cited by 44
Ferrigno, P. K., & Silver, P. A. (1999) · Oncogene · doi:10.1038/sj.onc.1203132 · Cited by 43
Jirmanova, L., Sarma, D. N., Jankovic, D. L., Mittelstadt, P. R., & Ashwell, J. D. (2008) · Blood · doi:10.1182/blood-2008-04-153304 · Cited by 37
Determinants That Control the Specific Interactions between TAB1 and p38α
Zhou, H., Zheng, M., Chen, J., Xie, C., Kolatkar, A. R., Zarubin, T., Ye, Z., Akella, R., Lin, S., Goldsmith, E. J., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3824-3834.2006 · Cited by 36
MAPK Kinase 3 Is a Tumor Suppressor with Reduced Copy Number in Breast Cancer
MacNeil, A. J., Jiao, S., McEachern, L. A., Yang, Y. J., Dennis, A., Yu, H., Xu, Z., Marshall, J. S., & Lin, T. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1310 · Cited by 33
p38 MAPK Down-regulates Fibulin 3 Expression through Methylation of Gene Regulatory Sequences
Arechederra, M., Priego, N., Vázquez‐Carballo, A., Sequera, C., Gutiérrez-Uzquiza, Á., Cerezo-Guisado, M. I., Ortiz-Rivero, S., Roncero, C., Cuenda, A., Guerrero, C., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.582239 · Cited by 30
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics
Lalaoui, N., Hänggi, K., Brumatti, G., Chau, D., Nguyen, N.-Y. N., Vasilikos, L., Spilgies, L. M., Heckmann, D. A., Ma, C., Ghisi, M., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.08.009 · Cited by 18
Beta-Like Importins Mediate the Nuclear Translocation of MAPKs
Zehorai, E., & Seger, R. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000056 · Cited by 14
Cited by
Diversity and versatility of p38 kinase signalling in health and disease
Canovas, B., & Nebreda, A. R. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00322-w · Cited by 657
Photodynamic Therapy—Current Limitations and Novel Approaches
Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.691697 · Cited by 599
The interaction between ferroptosis and inflammatory signaling pathways
Chen, Y., Fang, Z.-M., Yi, X., Wei, X., & Jiang, D.-S. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05716-0 · Cited by 567
Vascular Ageing: Mechanisms, Risk Factors, and Treatment Strategies
Ya, J., & Bayraktutan, U. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411538 · Cited by 57
Repurposing drugs targeting metabolic diseases for cancer therapeutics
Pillai U, J., Ray, A., Maan, M., & Dutta, M. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103684 · Cited by 31
Metadata
- Authors
- Martínez-Limón, A., Joaquin, M., Caballero, M., Posas, F., & de Nadal, E.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-03-11
- Volume
- 21
- Issue
- 6
- Pages
- 1913
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3010908253
- Cited by
- 411
- References
- 123
- FWCI
- 14.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.